Can-Fite Biopharma Ltd(CANF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CANF Can-Fite Biopharma Ltd

盘前交易 04-19 04:11:11 EDT

1.97

+0.01

+0.51%

最高2.07	最低1.96	成交量1.05万
今开2.00	昨收1.96	日振幅5.61%
总市值983.11万	流通市值982.83万	总股本499.04万
成交额2.10万	换手率0.21%	流通股本498.90万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CANF","market":"US","secType":"STK","nameCN":"Can-Fite Biopharma Ltd","latestPrice":1.97,"timestamp":1713470400000,"preClose":1.96,"halted":0,"volume":10456,"delay":0,"floatShares":4989000,"shares":4990428,"eps":-1.7913,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.01,"latestTime":"04-19 04:11:11 EDT","open":2,"high":2.07,"low":1.96,"amount":21033.781032,"amplitude":0.056122,"askPrice":2.46,"askSize":200,"bidPrice":0.7919,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.7913,"exchange":"AMEX","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713533400000},"adr":0,"listingDate":1384837200000,"adjPreClose":1.97,"adrRate":300,"postHourTrading":{"tag":"盘后","latestPrice":1.97,"preClose":1.97,"latestTime":"17:46 EDT","volume":3,"amount":5.97,"timestamp":1713476772323},"volumeRatio":0.5725562801172527},"requestUrl":"/m/hq/s/CANF","defaultTab":"news","newsList":[{"id":"2428320394","title":"Can Fite Biopharma Ltd盘中异动 下午盘大幅跳水5.29%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428320394","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428320394?lang=zh_cn&edition=full","pubTime":"2024-04-18 02:34","pubTimestamp":1713378848,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日02时34分，Can Fite Biopharma Ltd股票出现异动，股价急速下挫5.29%。截至发稿，该股报1.97美元/股，成交量5934股，换手率0.12%，振幅5.29%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.52%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041802340887e816c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041802340887e816c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427739038","title":"Can Fite Biopharma Ltd盘中异动 早盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427739038","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427739038?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:12","pubTimestamp":1713276769,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时12分，Can Fite Biopharma Ltd股票出现波动，股价急速拉升5.31%。截至发稿，该股报2.18美元/股，成交量2870股，换手率0.06%，振幅3.86%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为0.26%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162212497a532f14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162212497a532f14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427325507","title":"Can Fite Biopharma Ltd盘中异动 临近午盘股价大跌5.48%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427325507","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427325507?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:57","pubTimestamp":1712937451,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日23时57分，Can Fite Biopharma Ltd股票出现波动，股价大幅下挫5.48%。截至发稿，该股报2.16美元/股，成交量5064股，换手率0.10%，振幅6.14%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为0.89%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041223573187e7ffcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041223573187e7ffcd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426446904","title":"Can Fite Biopharma Ltd盘中异动 下午盘股价大涨7.15%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426446904","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426446904?lang=zh_cn&edition=full","pubTime":"2024-04-11 01:54","pubTimestamp":1712771665,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日01时54分，Can Fite Biopharma Ltd股票出现异动，股价急速上涨7.15%。截至发稿，该股报2.42美元/股，成交量1298股，换手率0.03%，振幅4.42%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为1.08%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041101542587e7f5cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041101542587e7f5cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426563123","title":"Can Fite Biopharma Ltd盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426563123","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426563123?lang=zh_cn&edition=full","pubTime":"2024-04-10 04:00","pubTimestamp":1712692836,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日04时00分，Can Fite Biopharma Ltd股票出现异动，股价急速下跌5.42%。截至发稿，该股报2.27美元/股，成交量1.9755万股，换手率0.40%，振幅10.33%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为0.14%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410040036861e44b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410040036861e44b1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425629905","title":"Can Fite Biopharma Ltd盘中异动 快速上涨6.01%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425629905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425629905?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:55","pubTimestamp":1712328947,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时55分，Can Fite Biopharma Ltd股票出现异动，股价快速拉升6.01%。截至发稿，该股报2.47美元/股，成交量9828股，换手率0.20%，振幅4.29%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.63%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052255487a5114b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052255487a5114b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424431396","title":"Can Fite Biopharma Ltd盘中异动 早盘股价大跌6.11%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424431396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424431396?lang=zh_cn&edition=full","pubTime":"2024-04-04 22:31","pubTimestamp":1712241062,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日22时31分，Can Fite Biopharma Ltd股票出现波动，股价大幅跳水6.11%。截至发稿，该股报2.15美元/股，成交量1817股，换手率0.04%，振幅6.11%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为0.09%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042231028af11e32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042231028af11e32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424025273","title":"Can Fite Biopharma Ltd盘中异动 大幅下挫6.06%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424025273","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424025273?lang=zh_cn&edition=full","pubTime":"2024-04-03 00:02","pubTimestamp":1712073727,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日00时02分，Can Fite Biopharma Ltd股票出现异动，股价急速下跌6.06%。截至发稿，该股报2.17美元/股，成交量1.4113万股，换手率0.23%，振幅8.66%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为1.75%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030002077a50ba5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030002077a50ba5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423848224","title":"Can Fite Biopharma Ltd2023财年实现净利润-7.63百万美元，同比增加24.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423848224","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2423848224?lang=zh_cn&edition=full","pubTime":"2024-03-29 14:14","pubTimestamp":1711692881,"startTime":"0","endTime":"0","summary":"12月31日，Can Fite Biopharma Ltd公布财报，公告显示公司2023财年净利润为-7.63百万美元，同比增加24.98%；其中营业收入为743000.00美元，同比减少8.27%，每股基本收益为-1.79美元。从资产负债表来看，Can Fite Biopharma Ltd总负债3.75百万美元，其中短期债务27000.00美元，资产负债比为2.67，流动比率为4.91。机构评级：截至2023年12月31日，当前有2家机构对Can Fite Biopharma Ltd目标价做出预测，其中目标均价为12.00美元，其中最低目标价为6.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291414488b70ce34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291414488b70ce34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419934121","title":"Can Fite Biopharma Ltd盘中异动 大幅下挫5.80%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419934121","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419934121?lang=zh_cn&edition=full","pubTime":"2024-03-15 03:18","pubTimestamp":1710443881,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日03时18分，Can Fite Biopharma Ltd股票出现波动，股价大幅下跌5.80%。截至发稿，该股报2.11美元/股，成交量1.0176万股，换手率0.17%，振幅6.25%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体跌幅为0.89%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150318018783009c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150318018783009c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419556505","title":"Can Fite Biopharma Ltd盘中异动 大幅下挫5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419556505","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419556505?lang=zh_cn&edition=full","pubTime":"2024-03-13 01:54","pubTimestamp":1710266064,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日01时54分，Can Fite Biopharma Ltd股票出现异动，股价快速跳水5.78%。截至发稿，该股报2.12美元/股，成交量4667股，换手率0.08%，振幅2.67%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.84%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313015424861dd90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313015424861dd90a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411547897","title":"Can Fite Biopharma Ltd盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411547897","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411547897?lang=zh_cn&edition=full","pubTime":"2024-02-15 23:34","pubTimestamp":1708011258,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日23时34分，Can Fite Biopharma Ltd股票出现异动，股价大幅上涨5.39%。截至发稿，该股报2.15美元/股，成交量1490股，换手率0.02%，振幅0.85%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.42%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021523341887e7039b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021523341887e7039b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408663856","title":"Can Fite Biopharma Ltd盘中异动 股价大跌5.19%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408663856","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408663856?lang=zh_cn&edition=full","pubTime":"2024-02-02 03:08","pubTimestamp":1706814488,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日03时08分，Can Fite Biopharma Ltd股票出现异动，股价快速跳水5.19%。截至发稿，该股报2.00美元/股，成交量1.047万股，换手率0.17%，振幅1.18%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为1.06%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202030808861d05b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202030808861d05b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407867856","title":"Can Fite Biopharma Ltd盘中异动 股价大涨8.16%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407867856","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407867856?lang=zh_cn&edition=full","pubTime":"2024-01-29 22:33","pubTimestamp":1706538785,"startTime":"0","endTime":"0","summary":"北京时间2024年01月29日22时33分，Can Fite Biopharma Ltd股票出现异动，股价快速上涨8.16%。截至发稿，该股报2.12美元/股，成交量3.2877万股，换手率0.54%，振幅4.52%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.31%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401292233058759832a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401292233058759832a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404568639","title":"Can Fite Biopharma Ltd盘中异动 急速下跌6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404568639","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404568639?lang=zh_cn&edition=full","pubTime":"2024-01-20 04:18","pubTimestamp":1705695498,"startTime":"0","endTime":"0","summary":"北京时间2024年01月20日04时18分，Can Fite Biopharma Ltd股票出现异动，股价大幅下挫6.50%。截至发稿，该股报1.87美元/股，成交量2437股，换手率0.04%，振幅3.53%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.16%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240120041819790a76f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240120041819790a76f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401476566","title":"Can Fite Biopharma Ltd盘中异动 大幅拉升6.03%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2401476566","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401476566?lang=zh_cn&edition=full","pubTime":"2024-01-05 23:31","pubTimestamp":1704468660,"startTime":"0","endTime":"0","summary":"北京时间2024年01月05日23时31分，Can Fite Biopharma Ltd股票出现异动，股价快速上涨6.03%。截至发稿，该股报2.11美元/股，成交量6663股，换手率0.11%，振幅4.02%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.09%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010523310087985312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010523310087985312&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400089576","title":"Can Fite Biopharma Ltd盘中异动 临近收盘快速跳水5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400089576","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400089576?lang=zh_cn&edition=full","pubTime":"2024-01-03 05:05","pubTimestamp":1704229535,"startTime":"0","endTime":"0","summary":"北京时间2024年01月03日05时05分，Can Fite Biopharma Ltd股票出现波动，股价快速下挫5.91%。截至发稿，该股报2.07美元/股，成交量1.8473万股，换手率0.31%，振幅7.25%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为1.48%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010305053587e62e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010305053587e62e14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392999912","title":"Can Fite Biopharma Ltd盘中异动 早盘股价大涨6.17%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392999912","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392999912?lang=zh_cn&edition=full","pubTime":"2023-12-18 22:41","pubTimestamp":1702910463,"startTime":"0","endTime":"0","summary":"北京时间2023年12月18日22时41分，Can Fite Biopharma Ltd股票出现波动，股价快速拉升6.17%。截至发稿，该股报2.15美元/股，成交量7145股，换手率0.12%，振幅0.00%。Can Fite Biopharma Ltd股票所在的生物技术行业中，整体涨幅为0.15%。Can Fite Biopharma Ltd公司简介：Can Fite Biofarma Ltd 是一家先进的临床阶段药物开发公司，其平台技术旨在解决数十亿美元的癌症、肝脏和炎症疾病治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231218224104830d250f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231218224104830d250f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.canfite.com","stockEarnings":[{"period":"1week","weight":-0.136},{"period":"1month","weight":-0.0963},{"period":"3month","weight":0.0207},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.1006},{"period":"ytd","weight":-0.1045}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Can-fite Biopharma Ltd.创建于1994年9月11日，该公司是一家临床阶段的生物制药公司，专注于研发治疗自身免疫性炎症，肿瘤和眼科疾病的口服生物小分子治疗产品。该平台技术利用Gi蛋白相关的A 3 AR作为治疗靶标。A 3 AR高度表现在炎性细胞和癌细胞上，但在正常细胞中没有显著表现，这表明该受体可以作为药物介入的独特目标。该管道药物是人工合成的，属于高度特定的受体激动剂和变构调节剂，配体或分子，而这些分子在将A 3 AR作靶，并与靶蛋白结合时，发起了分子事件。","yearOnYearQuotes":[{"month":1,"riseRate":0.181818,"avgChangeRate":-0.082314},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.023897},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.059681},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.053296},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039133},{"month":6,"riseRate":0.3,"avgChangeRate":-0.02426},{"month":7,"riseRate":0.2,"avgChangeRate":-0.02715},{"month":8,"riseRate":0.4,"avgChangeRate":-0.002853},{"month":9,"riseRate":0.4,"avgChangeRate":0.050189},{"month":10,"riseRate":0.2,"avgChangeRate":-0.057851},{"month":11,"riseRate":0.6,"avgChangeRate":0.090884},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.060826}],"exchange":"AMEX","name":"Can-Fite Biopharma Ltd","nameEN":"Can Fite Biofarma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Can-Fite Biopharma Ltd(CANF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Can-Fite Biopharma Ltd(CANF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Can-Fite Biopharma Ltd,CANF,Can-Fite Biopharma Ltd股票,Can-Fite Biopharma Ltd股票老虎,Can-Fite Biopharma Ltd股票老虎国际,Can-Fite Biopharma Ltd行情,Can-Fite Biopharma Ltd股票行情,Can-Fite Biopharma Ltd股价,Can-Fite Biopharma Ltd股市,Can-Fite Biopharma Ltd股票价格,Can-Fite Biopharma Ltd股票交易,Can-Fite Biopharma Ltd股票购买,Can-Fite Biopharma Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Can-Fite Biopharma Ltd(CANF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Can-Fite Biopharma Ltd(CANF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}